These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 3012067

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
    Kokubun S, Prod'hom B, Becker C, Porzig H, Reuter H.
    Mol Pharmacol; 1986 Dec; 30(6):571-84. PubMed ID: 2431263
    [Abstract] [Full Text] [Related]

  • 23. The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel.
    Sieber M, Nastainczyk W, Zubor V, Wernet W, Hofmann F.
    Eur J Biochem; 1987 Aug 17; 167(1):117-22. PubMed ID: 2441986
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Calcium channel receptor sites for (+)-[3H]PN 200-110 in coronary artery.
    Yamada S, Kimura R, Harada Y, Nakayama K.
    J Pharmacol Exp Ther; 1990 Jan 17; 252(1):327-32. PubMed ID: 2153804
    [Abstract] [Full Text] [Related]

  • 26. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ, Tuana BS.
    Can J Physiol Pharmacol; 1990 Nov 17; 68(11):1389-95. PubMed ID: 1962734
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
    Haase H, Wallukat G, Vetter R, Will H.
    Biomed Biochim Acta; 1987 Nov 17; 46(8-9):S363-9. PubMed ID: 2829862
    [Abstract] [Full Text] [Related]

  • 34. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
    Schmid A, Romey G, Barhanin J, Lazdunski M.
    Mol Pharmacol; 1989 Jun 17; 35(6):766-73. PubMed ID: 2543910
    [Abstract] [Full Text] [Related]

  • 35. Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.
    Goll A, Glossmann H, Mannhold R.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov 17; 334(3):303-12. PubMed ID: 3027587
    [Abstract] [Full Text] [Related]

  • 36. Pharmacology of (-) [3H]D888 (desmethoxyverapamil) binding sites in rat skeletal membranes.
    Atrakchi AH, Kunysz E, Michel AD.
    Proc West Pharmacol Soc; 1987 Nov 17; 30():127-30. PubMed ID: 2819887
    [No Abstract] [Full Text] [Related]

  • 37. [Photoactivated radioactive analogs of calcium antagonists of 1,4-dihydropyridine series: synthesis and covalent labeling of the receptor in rabbit skeletal muscle].
    Soldatov NM.
    Biokhimiia; 1988 Aug 17; 53(8):1247-55. PubMed ID: 2847815
    [Abstract] [Full Text] [Related]

  • 38. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
    Dunn SM, Bladen C.
    Biochemistry; 1991 Jun 11; 30(23):5716-21. PubMed ID: 1645998
    [Abstract] [Full Text] [Related]

  • 39. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker.
    Suh-Kim H, Wei X, Birnbaumer L.
    Mol Pharmacol; 1996 Nov 11; 50(5):1330-7. PubMed ID: 8913365
    [Abstract] [Full Text] [Related]

  • 40. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
    Knaus HG, Striessnig J, Hering S, Marrer S, Schwenner E, Höltje HD, Glossmann H.
    Mol Pharmacol; 1992 Feb 11; 41(2):298-307. PubMed ID: 1311409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.